| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.00026 | 1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.00022 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.00022 | 1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.00018 | 1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 8.6e-05 | 1 |